Skip to main content
Business

Moderna’s stock jumps after biotech raises sales outlook

Moderna’s stock jumps after biotech raises sales outlook

Feed excerpt — reported by MarketWatch

The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at MarketWatch →

Original Source

This article was syndicated from MarketWatch. All rights remain with the original publisher.